SCHEMBL30006033

SCHEMBL30006033

Cc1c(-c2cccc3c2ccn3CC(F)F)c2c(c3c1-n1c(C)nnc1C(C)(C)N3)CCO2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23647886 1.00 — —
SCHEMBL23658620 0.93 — —
SCHEMBL30006206 0.93 — —
SCHEMBL30006609 0.91 — —
SCHEMBL23658841 0.91 — —
SCHEMBL23647822 0.84 — —
SCHEMBL30005891 0.84 — —
SCHEMBL23658813 0.84 — —
SCHEMBL23647832 0.83 HTR6 (0.31) —
SCHEMBL30006026 0.83 HTR6 (0.31) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4090660-A1 QUINOXALINE DERIVATIVES Grünenthal GmbH (DE) 2022-11-23 — — EP claimed
EP-4090660-A1 QUINOXALINE DERIVATIVES Grünenthal GmbH (DE) 2022-11-23 — — EP disclosed
Send feedback